141 related articles for article (PubMed ID: 3318375)
1. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
[TBL] [Abstract][Full Text] [Related]
2. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
4. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
7. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
Chrysant SG; Miller E
Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
[TBL] [Abstract][Full Text] [Related]
8. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
Nikkilä M; Inkovaara J; Heikkinen J
Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
10. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
12. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
[TBL] [Abstract][Full Text] [Related]
13. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
[TBL] [Abstract][Full Text] [Related]
14. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
[TBL] [Abstract][Full Text] [Related]
15. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
Tonkin AL; Wing LM; Russell AE; West MJ; Bune AJ; Morris MJ; Cain MD; Chalmers J
J Hypertens; 1990 Nov; 8(11):1015-9. PubMed ID: 1963183
[TBL] [Abstract][Full Text] [Related]
16. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
Daniels AR; Opie LH
Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
[TBL] [Abstract][Full Text] [Related]
17. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial.
Kawanishi DT; Leman RB; Pratt CM; O'Rourke RA
Am J Cardiol; 1987 Dec; 60(17):29I-35I. PubMed ID: 2891291
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
Pool PE; Seagren SC; Salel AF
Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
